arrow
S

Samuel J. Redmond

peter doherty institute for infection and immunity
H指数:11
被引数:427

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Specific targeting of MR1-antigen complexes using nanobodies

利用纳米抗体特异性靶向MR1-抗原复合物

2026-09-250
PRE
Butyrophilin 3A1 engages the CDR2δ loop of the Vγ9Vδ2+ T cell receptor

但yrophilin 3A1与Vγ9Vδ2<sup>+</sup> T细胞受体的CDR2δ环相互作用

2026-09-080
OAAI
Vγ9Vδ2 T cells recognize butyrophilin 2A1 and 3A1 heteromers

Vγ9vδ2t细胞识别嗜丁基蛋白2A1和3A1异聚体

2024-07-161
PRE
Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster
2023-12-015
OAAI
Newborn and child-like molecular signatures in older adults stem from TCR shifts across human lifespan

老年人的新生儿和儿童样分子特征源于人类寿命的TCR变化

2023-09-257
OAAI
Broad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccine

SARS-CoV-2受体结合域蛋白疫苗介导的对SARS-CoV-2相关变异的广泛免疫

2023-06-017
OAAI
A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2

用于中和针对SARS-CoV-2的抗体的护理点侧流测定

2021-12-0124
OAAI
Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay
2021-08-2325
OA